We’re thrilled to announce that Jenn D'Arcangelo has been promoted to Chief Operating Officer (COO) and appointed to the Ambit Board of Directors. Jenn has been a driving force at Ambit since joining us three years ago, shaping our culture, scaling our operations, and leading with clarity and conviction. Her promotion reflects the impact she’s had—and will continue to have—on our growth and mission. Please join us in congratulating Jenn on this well-earned recognition! #leadership #ambitcare #COO #boardofdirectors #teamambit
Ambit Inc.
Business Consulting and Services
Morristown, New Jersey 7,750 followers
Providing solutions to better navigate the inherent challenges of rare and specialty disease
About us
Ambit is a solutions company. Because that’s exactly what we deliver. We know how complex biopharma problems can be—so we meet them with best-in-class talent, cutting edge data & analytics technology, and the expertise earned through decades of work in rare and specialty diseases. With an interconnected approach from analysis, to insight, to activation, we deliver products and services that change the trajectory of our clients’ businesses. So give us your biggest challenges. The solution is here.
- Website
-
https://www.ambitinc.com/
External link for Ambit Inc.
- Industry
- Business Consulting and Services
- Company size
- 51-200 employees
- Headquarters
- Morristown, New Jersey
- Type
- Privately Held
- Founded
- 2021
- Specialties
- Data, Rare Disease, Artificial Intelligence, Specialty Disease, Consulting, Analytics, Digital Transformation, Digital, Patient Identification, Strategy, and Commercialization
Locations
-
Primary
72 Miller Road
Morristown, New Jersey 07960, US
Employees at Ambit Inc.
-
Lisa Van Ess
Talent & Culture Executive | People Experience Leader | CPO | CHRO | Inclusive Collaborator | Ally | Coach
-
Rob Sederman
Co-Founder and CEO at Ambit Inc
-
Ned Kitfield
Co-Founder and CCO at Ambit Inc
-
Birnur Ozbas-Erdem
SVP, Head of Analytics and Data Products at Ambit Inc.
Updates
-
Finding the right patients—faster—can change everything. At Ambit, we’re redefining how specialty and rare disease patients are identified and activated. This video breaks down how our solutions—Dynamic LeadGen and PatientActivate—streamline patient finding for both clinical trials and approved therapies. In rare disease, especially, the stakes are high. See how we’re helping teams move with more speed, precision, and impact: https://hubs.li/Q03BclSD0 #patientfinding #patientactivate #dynamicleadgen
-
Straight from Ned himself. Learn more about our Commercial & Medical strategy solutions: https://hubs.li/Q03BcfP50 #trustedpartner #commercialstrategy #commercialization
-
-
Humble brag because #TeamAmbit is simply the best. Meet the incredibly talented individuals who make up our one-of-a-kind team: https://hubs.li/Q03Bc4nB0 #teamambit
-
-
With analytics-ready data built for commercialization, we deliver faster, deeper insights without the lag or licensing fees. You get more than numbers. You get answers. Discover our Data & Analytics solutions: https://hubs.li/Q03Bb-_K0 #data #analytics #insights #commercialization
-
Big congrats to the team at Praxis Precision Medicines, Inc. on this exciting milestone! These results mark a meaningful step forward in the pursuit of next-gen therapies for focal epilepsy. #focalepilepsy #epilepsy #clinicaltrials
Today, we announced positive topline results from the phase 2 RADIANT study of vormatrigine in patients with focal epilepsy. Highlighting the potential for vormatrigine as a next-generation therapy for epilepsy. For additional details, read the press release here: https://lnkd.in/eehTtigW #PraxisMedicines #Epilepsy #Biotech #ClinicalTrials #Neurology #FocalEpilepsy
-
The right strategy can change everything. At Ambit, we help pharma and biotech teams tackle their toughest challenges with smart, data-driven Commercial & Medical Strategy solutions. Whether you’re preparing for a launch, shaping your brand strategy, or building your medical affairs plan, we’re here to guide you every step of the way. Curious what sets us apart? Learn more: https://hubs.li/Q03xVF0H0 #commercialstrategy #medicalstrategy #biopharmaconsulting
-
Your launch dashboard only gets you so far. KPIs and trackers might answer 25% of what you’ll need to know. The rest? It’s the why, where, and what-now—questions that emerge in real time. Ambit’s Integrated Launch Room combines data, analytics, and strategy in one nimble team to give you the answers that matter—fast. The solution is here. Discover more today: https://hubs.li/Q03xVJ9l0 #integratedlaunchroom #KPI #data #analytics
-
-
Love letters straight from the people who make Ambit amazing. 💌 #testimonials #companyculture #biopharmainnovation #loveletters
-
Don't be an outsider. Join us - learn more and subscribe here: https://hubs.li/Q03xFqty0 #ambitnewsletter #newslettersignup